UnitedHealth’s stock fell after the report about the fraud probe was published. It was the latest in a series of shocks which has seen the company’s share price collapse by over 50 percent in ...

The company’s stock has declined over its financial performance and the sudden replacement of its CEO.

Antitrust leadership is considering redirecting its investigation into Unitedhealth Group (NYSE:UNH) to focus on the company’s pharmacy benefits management (PBM) unit, according to The Capital Forum, ...

UnitedHealth Group is under investigation by the Justice Department for its Medicare Advantage billing practices, The Wall Street Journal reported Friday. The civil fraud probe is looking at ...

UnitedHealth is under investigation by the Department of Justice for possible criminal Medicare fraud, The Wall Street Journal reported, adding to ongoing antitrust and civil fraud cases facing ...

UnitedHealth – a $400 billion company that owns the largest US health insurer, doctor practices and a pharmacy-benefit manager – also faces a DOJ-led antitrust probe.

SAN FRANCISCO, June 26, 2025 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP advises UnitedHealth Group investors that the firm is investigating potential legal claims following revelations that ...

UnitedHealth Group s(UNH) hares plunged 16% to a five-year low after reports that the U.S. Department of Justice is investigating the company for potential Medicare fraud, compounding recent ...

DOJ launched probe into UnitedHealth for insider trading and attempted to stop monopoly UnitedHealthcare CEO Brian Thompson was shot and killed in Manhattan on ...

UnitedHealth's stock has tumbled 45.8% in 2025, enough to make it the S&P 500's worst performer this year. In comparison, the Health Care Select Sector SPDR ETF XLV has lost 5.2% this year and the ...

UnitedHealth Group ... the DOJ’s probe, ... — including a civil inquiry into its Medicare billing practices and continuing investigations into potential antitrust violations. ...